loader from loading.io

Antibody engineering: the importance of collaboration and successful partnerships

The Drug Discovery World Podcast

Release Date: 07/16/2021

Unlock the potential of complex human liver data show art Unlock the potential of complex human liver data

The Drug Discovery World Podcast

In theseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Quin Wills, Co-founder and CSO of Ochre Bio, a company whose scientists are working in collaboration with AI to unlock the potential of complex human liver data. Ochre's lab in Oxford takes different types of human cells from donor livers, which they combine to build components of the liver from scratch. These ‘bottom up’ models allow them to flexibly study...

info_outline
DDW Highlights: 19 February 2024 show art DDW Highlights: 19 February 2024

The Drug Discovery World Podcast

The latest episode of the  is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week our news highlights focus on skin conditions, with positive updates on hidradenitis suppurativa, systemic sclerosis, wound-healing, and other dermatological conditions like atopic dermatitis and vitiligo. You can listen below, or find The Drug Discovery World Podcast on , and  

info_outline
DDW Events SLAS2024: Solving the diagnostic odyssey with multi-omics show art DDW Events SLAS2024: Solving the diagnostic odyssey with multi-omics

The Drug Discovery World Podcast

For this year’s SLAS2024 conference in Boston (which takes place 3-7 February), DDW’s Megan Thomas narrates articles from the DDW as part of the DDW Events podcast series. This is episode five,  Catherine Brownstein is an Assistant Professor in Pediatrics at Harvard Medical School and the Assistant Director of the Molecular Genetics Core Facility at Boston Children's Hospital. Her current work focuses on advancing the fields of genome sequencing and analysis, with an emphasis on identifying complex structural variation. She spoke with me on how genomics can advance drug discovery...

info_outline
DDW Events SLAS2024: The building blocks of AI success stories show art DDW Events SLAS2024: The building blocks of AI success stories

The Drug Discovery World Podcast

For this year’s SLAS2024 conference in Boston (which takes place 3-7 February), DDW’s Megan Thomas narrates articles from the DDW as part of the DDW Events podcast series. This is episode four, . Dr Mike Tarselli, Chief Scientific & Knowledge Officer at TetraScience, was Scientific Director of SLAS until 2020, and will be chairing his first event this year. He shares his insight with me in this episode.

info_outline
DDW Events SLAS2024: Connecting academia, industry and the public show art DDW Events SLAS2024: Connecting academia, industry and the public

The Drug Discovery World Podcast

For this year’s SLAS2024 conference in Boston (which takes place 3-7 February), DDW’s Megan Thomas narrates articles from the DDW as part of the DDW Events podcast series. This is episode three, . Erin Welsh, PhD, is a disease ecologist and epidemiologist now working full-time as a science communicator. Erin Allmann Updyke, MD, PhD is an epidemiologist and disease ecologist currently in a medical residency programme to complete her training. Together, they make up This Podcast Will Kill You. Ahead of being a keynote speaker at SLAS 2024, Welsh shares insight with DDW.

info_outline
DDW Events SLAS2024: Where is the Ignite Theatre tech leading us? show art DDW Events SLAS2024: Where is the Ignite Theatre tech leading us?

The Drug Discovery World Podcast

For this year’s SLAS2024 conference in Boston (which takes place 3-7 February), DDW’s Megan Thomas narrates articles from the DDW as part of the DDW Events podcast series. This is episode two, Where is the Ignite Theater tech leading us? At this year's SLAS event, DDW has curated a track taking place in the Ignite Theater, sponsored by Integra Biosciences and Hamamatsu Corporation. It will explore technologies being used for drug discovery and how they get from lab to patient.

info_outline
DDW Events SLAS2024: A welcome to SLAS 2024 show art DDW Events SLAS2024: A welcome to SLAS 2024

The Drug Discovery World Podcast

For this year’s SLAS2024 conference in Boston (which takes place 3-7 February), DDW’s Megan Thomas narrates articles from the DDW as part of the DDW Events podcast series. This is episode one, called, “A welcome to SLAS 2024”, which includes two comment pieces. Thomas wrote the first one, “The journey from lab to patient”, which focuses on the theme of the track curated by DDW taking place in the Ignite Theater at SLAS 2024. The second is from SLAS Director of Marketing & Communications, Jill Hronek, called “Innovation at every turn: Hello SLAS2024”, in which Hronek...

info_outline
DDW Highlights: 29 January 2024 show art DDW Highlights: 29 January 2024

The Drug Discovery World Podcast

The latest episode of the  is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  In the same week that it was revealed that breast cancer was the most studied disease area in 2023 for the third year running, there were a number of promising developments in the treatment of colorectal, pancreatic and lung cancer and leukaemia. You can listen below, or find The Drug Discovery World Podcast on ,  and  

info_outline
A safer option to opioid pain killers show art A safer option to opioid pain killers

The Drug Discovery World Podcast

In theseries, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business.    In this episode, Megan Thomas is in conversation with Dr Lynn Kirkpatrick, CEO of Ensysce Biosciences. As we all know, the opioid epidemic is one of the biggest issues in the United States today. As of late, it has been cracked down on to prevent overdosing and abuse of opioids, but it still leaves patients with a need for pain medication. Currently, Ensynsce Biosciences is headed into Phase III clinical...

info_outline
DDW Highlights: 22 January 2024 show art DDW Highlights: 22 January 2024

The Drug Discovery World Podcast

The latest episode of the  is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  With seasonal illnesses running amok in the western hemisphere at the moment, it is perhaps not surprising that this week’s news highlights focus on viruses and immunity. You can listen below, or find The Drug Discovery World Podcast on ,  and  

info_outline
 
More Episodes

Mathur talks about Twist’s antibody expertise, drawing on the company’s experience and looking at the importance of collaboration. The company has created some successful partnerships and she explains what these look like, why they have been fruitful, and how they have enabled Twist to use its capabilities to maximum effect.

Listen now to hear Mathur discuss the company philosophy, how the pandemic has affected the business, its partnership experience and what the future holds for this forward-thinking company.